Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pedersen-Bjergaard

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|January 19, 2000
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromereM K Andersen, J Pedersen-Bjergaard
Leukemia|December 26, 2001
Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapyD H Christiansen, J Pedersen-Bjergaard
Haematologica|July 24, 1998
Secondary or therapy-related MDS and AML and their chromosome aberrations: important to study but difficult to establish causalityJ Pedersen-Bjergaard, M K Andersen
Blood|May 15, 1994
The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformationJ Pedersen-Bjergaard, J D Rowley
Scandinavian Journal of Haematology|April 1, 1977
Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemiaA M Worm, J Pedersen-Bjergaard
Cancer|June 1, 1990
High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancerM Andersson, P Philip, J Pedersen-Bjergaard
Cancer Genetics and Cytogenetics|August 1, 1994
Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformationJ Pedersen-Bjergaard, B Johansson, P Philip
Scandinavian Journal of Haematology|February 1, 1986
Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of manJ Pedersen-Bjergaard, P Andersson, P Philip
Acta Medica Scandinavica|July 1, 1973
Disodium cromoglycate in bronchial asthma. A double-blind trial in adult patientsJ Georg, I Hansen, J Pedersen-Bjergaard
Cancer Genetics and Cytogenetics|November 1, 1987
Translocations and deletions with breakpoint on 21q are nonrandomly associated with treatment-related acute nonlymphocytic leukemia and preleukemiaN Keldsen, P Philip, J Pedersen-Bjergaard
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|January 19, 2000
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromereM K Andersen, J Pedersen-Bjergaard
Leukemia|December 26, 2001
Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapyD H Christiansen, J Pedersen-Bjergaard
Haematologica|July 24, 1998
Secondary or therapy-related MDS and AML and their chromosome aberrations: important to study but difficult to establish causalityJ Pedersen-Bjergaard, M K Andersen
Blood|May 15, 1994
The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformationJ Pedersen-Bjergaard, J D Rowley
Scandinavian Journal of Haematology|April 1, 1977
Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemiaA M Worm, J Pedersen-Bjergaard
Cancer|June 1, 1990
High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancerM Andersson, P Philip, J Pedersen-Bjergaard
Cancer Genetics and Cytogenetics|August 1, 1994
Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformationJ Pedersen-Bjergaard, B Johansson, P Philip
Scandinavian Journal of Haematology|February 1, 1986
Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of manJ Pedersen-Bjergaard, P Andersson, P Philip
Acta Medica Scandinavica|July 1, 1973
Disodium cromoglycate in bronchial asthma. A double-blind trial in adult patientsJ Georg, I Hansen, J Pedersen-Bjergaard
Cancer Genetics and Cytogenetics|November 1, 1987
Translocations and deletions with breakpoint on 21q are nonrandomly associated with treatment-related acute nonlymphocytic leukemia and preleukemiaN Keldsen, P Philip, J Pedersen-Bjergaard
Pageof 10